Home > Boards > US Listed > Biotechs >

Seattle Genetics (SGEN)

SGEN RSS Feed
Add SGEN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/23/2020 5:13:55 PM - Followers: 25 - Board type: Free - Posts Today: 0

http://www.seattlegenetics.com

http://finance.yahoo.com/q/ks?s=SGEN

http://www.form4oracle.com/company?cik=0001060736&ticker=sgen

Seattle Genetics, Inc. operates as a biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer, including lymphoma, multiple myeloma, leukemia, and solid tumors. The company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize SGN-40, a humanized monoclonal antibody that is in phase I and phase II clinical development for patients with diffuse large B-cell lymphoma and multiple myeloma. It also has three other proprietary programs in ongoing clinical trials: SGN-33, SGN-35, and SGN-30. The company's SGN-33 is in a phase IIb clinical trial for the patients with acute myeloid leukemia or myelodysplastic syndromes; and SGN-30 and SGN-35 are in phase II clinical trails for the treatment of CD30-positive hematologic malignancies, such as Hodgkin's disease and anaplastic large cell lymphoma. In addition, it developed proprietary antibody-drug conjugate (ADC) technology comprising highly potent synthetic drugs and stable linkers for attaching the drugs to monoclonal antibodies. The company's product candidates also include SGN-70, a humanized anti-CD70 monoclonal antibody with potent effector function and intrinsic cell-killing ability; and SGN-75, which consists of an anti-CD70 monoclonal antibody linked to an auristatin derivative using its proprietary ADC technology. Seattle Genetics has license agreements with Bayer, CuraGen, Progenics, MedImmune, and PDL BioPharma to use its proprietary ADC technology with their monoclonal antibodies; and an ADC co-development agreement with Agensys and Celera Genomics. The company was founded in 1997 and is headquartered in Bothell, Washington
.





SGEN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SGEN News: Seattle Genetics to Host Conference Call & Webcast Discussion of Fourth Quarter & Full Year 2019 Financial Results on Februar... 01/21/2020 08:30:00 AM
SGEN News: Seattle Genetics Achieves Milestone Following European Commission Approval of Roche’s Polivy® (Polatuzumab Vedotin) 01/21/2020 08:00:00 AM
SGEN News: Current Report Filing (8-k) 01/16/2020 04:56:53 PM
SGEN News: Seattle Genetics to Present at the J.P. Morgan Healthcare Conference 01/06/2020 08:00:00 AM
SGEN News: Statement of Changes in Beneficial Ownership (4) 12/23/2019 05:28:01 PM
PostSubject
#254   https://mobile.twitter.com/SeattleGenetics/status/1220436036997660672 mellow fellow 01/23/20 05:13:55 PM
#253   Seattle Genetics Achieves Milestone Following European Commission Approval mellow fellow 01/21/20 05:33:47 PM
#252   $SGEN bears are running https://news.squeezereport.com/short-squeeze whytestocks 11/12/19 11:25:23 AM
#251   Seattle Genetics will receive an upfront payment and Phosphene 11/06/19 12:16:41 PM
#250   News: $SGEN Seattle Genetics Announces Positive Topline Results whytestocks 10/21/19 12:45:26 PM
#249   News: $SGEN Here's Why Seattle Genetics Stock Jumped whytestocks 09/30/19 02:00:22 PM
#248   News: $SGEN Initial Results from MOUNTAINEER Trial Show whytestocks 09/29/19 09:10:29 AM
#247   News: $SGEN Seattle Genetics and Astellas Announce Results whytestocks 09/28/19 08:00:21 AM
#246   SGEN DAY PennyStock Alert 09/16/19 09:06:04 AM
#245   “The current standard of care for initial treatment crudeoil24 11/16/18 03:00:53 PM
#244   SGEN is a great $$$$$ opportunity. crudeoil24 11/16/18 02:52:58 PM
#243   Also, Seattle pounded the Packers last night! crudeoil24 11/16/18 02:52:19 PM
#242   Agree! crudeoil24 11/16/18 02:51:36 PM
#241   https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626079.htm crudeoil24 11/16/18 02:50:15 PM
#240   Boom! > FDA approves Adcetris > SGEN crudeoil24 11/16/18 02:31:48 PM
#239   SGEN is looking to bust $70. I think 46er 06/12/18 03:20:32 PM
#238   $SGEN OVER BOUGHT. RETRACE TO $20 imo coming SpotOnTrade 11/29/17 12:44:51 AM
#237   There's a whole little flock of new collaborations shub 10/11/17 02:25:41 PM
#236   It sure is an incoherent and dispersed bunch shub 10/03/17 03:39:49 PM
#235   Thanks for the tips. I'll sure take a cdaniel394 10/03/17 03:20:48 PM
#234   CD: Took a nibble of AMFE but it shub 10/03/17 03:17:41 PM
#233   Thanks C Daniel: shub 10/03/17 02:44:03 PM
#232   Thank you. Just had a friends brother who cdaniel394 10/03/17 02:42:51 PM
#231   With all their drugs in testing or trials, shub 10/03/17 02:41:34 PM
#230   Also, I don't know your risk tolerance, but cdaniel394 10/03/17 02:38:19 PM
#229   Quite all right. Been in SGEN since the cdaniel394 10/03/17 02:35:40 PM
#228   Sorry, wasn't paying attention to the time line, shub 10/02/17 03:31:25 PM
#227   Easy to make that call when hindsight is 20/20. cdaniel394 10/02/17 03:27:25 PM
#226   nope, shub 10/02/17 03:23:39 PM
#225   This up big on take over speculation? cdaniel394 08/31/17 01:23:12 PM
#224   Taking a beating on a week of mixed news. shub 06/27/17 03:16:48 PM
#223   Prescient purchase North...$36 for me. shub 01/27/17 03:57:08 PM
#222   Nicely above our purchase price[basis] many years ago north40000 01/27/17 03:37:46 PM
#221   Thanks North. shub 01/27/17 02:13:50 PM
#220   The post you replied to was made a north40000 01/26/17 04:45:16 PM
#219   Our main product is not free of possible shub 01/26/17 03:03:32 PM
#218   Clinical hold on a SGEN trial...PM trading shares north40000 12/27/16 08:48:10 AM
#217   Up 15% on Ph3 trial enlistment filled. shub 11/09/16 02:55:55 PM
#216   SGEN bullish 55.18 stocktrademan 10/08/16 01:20:59 PM
#215   SGEN H D W TREND1 08/10/16 03:04:30 PM
#214   SGEN DAY TREND1 07/29/16 03:38:02 PM
#213   Delving Into Seattle Genetics’s Upcoming Readout http://marketexclusive.com/de trendmkr 07/28/16 02:48:23 PM
#212   Seattle Genetics Highlights Vadastuximab Talirine (SGN-CD33A) Data in Mitshu35 07/25/16 09:48:02 AM
#211   *****Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that TREND1 07/16/16 03:28:06 PM
#210   Short % of Float = 24.5% TREND1 07/16/16 01:15:12 PM
#209   ***** SGEN DAY TREND1 07/16/16 01:06:50 PM
#208   Inst % Owned = 99% TREND1 07/16/16 12:59:13 PM
#207   FLOAT=61 MILLION TREND1 07/16/16 12:58:20 PM
#206   EPS=-.93 TREND1 07/16/16 12:57:17 PM
#205   *****AML Therapies: Seattle Genetics Vs. GlycoMimetics TREND1 07/16/16 11:28:41 AM
PostSubject